RAPT Q1 2020 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RAPTRAPT Therapeutics, Inc.

$959M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$935,000

Gross Profit

$935,000100.0% margin

Operating Income

-$13M-1394.3% margin

Net Income

-$13M-1405.2% margin

EPS (Diluted)

$-4.52

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$151M

Total Liabilities

$19M

Stockholders' Equity

$132M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$935,000	$0	—
Gross Profit	$935,000	$0	—
Operating Income	-$13M	-$10M	-36.6%
Net Income	-$13M	-$9M	-43.0%